Member Info for Globetrotter184

Hot Black. Perfectly described.

Point taken Ahfam. I have only been in since last October and topped up in January of this year and have an average price of 2p. You obviously have more experience in this share.

Guys keep feet firmly on the ground. Situation looks very promising but SP targets being mentioned are at this point unrealistic. I will be very happy with a nice gradual rise with phases of consolidation as the news flow is digested. Takeover talk is also premature in my opinion.

Keep your feet firmly on the ground. Unsubstantiated wild share price predictions do more harm than good. Moving in right direction but still a very long way to go.

Porky the current SP is discounting the fact that the DHSC contract is a goner and a write off. Too much depended on this contract . Now company has to convince on different revenue streams being sustainable. Still a great company but lost the advantage of being the first off the blocks. Now depends on roll out success on its pipeline. I do not see a short term catalyst which would justify a hefty price rise.

Porky i admire your confidence. The market though is not confident of a sustainable stream of revenues going forward.

You hit the nail on the head. Its the permanent revenue streams that the market needs to be convinced about. At the moment there is doubt and SP reflecting this. Another " cautious" outlook statement by the GM will hurt the SP.

Agree with you JRDC. A lot of aspects taken for granted. And what if the results are below market expectations ? Talk about Novacyt being the "gold standard" is futile if not backed up by hard facts not wishful thinking. The last RNS provided temporary relief but was short lived and once again investors sucked up to the hike in price. With Government contract a goner there is no clear visibility for the level of future earnings. The SP is reflecting this. See this as a promising long term situation and nothing else.

Neilrich Would be interesting to see how you have come to a "well north GBP 15 " valuation.

Said this before. The market is not interested in the present sales figures but more the medium/long term outlook. There is no clarity as to the sustainability of earnings. Market will be assessing what the GM has to say. He has to be more specific and convincing. No doubt about the quality of the product but there are many players and the distinct advantage of being first in the market has now been lost. All this conspiracy talk about MM manipulation seems to me a bit overdone. Vague talk after results will certainly not help the SP at all.

Please keep your feet firmly on the ground.Mister E Trayda. Lets see the figures first and hopefully the SP will react. Problem is that market is looking beyond and to the sustainability of earnings.Market is not yet convinced. As to the shorters eventually they will die out. Value when sustained will win the day.

good observation levin

Porky do you have any idea what level of shorting there is ?

Agree with you as well GDWK. Nice weekend to all

Totally untrue. I am not a pessimist just a realist with feet on the ground. I hold a substantial amount of Nova at average Eur 1.91. Never traded and believe in long term. But clearly the " optimists" on this board are myopic to reality. Maybe it would have been good for me to top slice and trade. My mistake and i pay for it.

That's 2020. !!

So GDR rises 21/25% on news of acceptance of covid test in India by Indian Regulator. Where is Novacyt "gold standard" test in all this. So concrete results please not hearsay or wishful thinking. Clearly Our PCR tests not commercially competitive . if we cannot penetrate the Indian market when there is a massive opportunity to do so then i am afraid we are missing boat. In my view we have already lost the advantage of being first out. The SP destined to be lethargic.

Totally in agreement with your line of reasoning Peep.

Once more many comments here have their merit but predominantly based on suppositions , gut feelings, sales and contracts which cannot be confirmed and the list is endless. The hype in the price after what after all was a decently worded RNS has fizzled out. Lets patiently wait for confirmation of contracts and results as the ramping favours only the traders who are having a field day. Many investors have made good money here but equally many investors were sucked up in the hype and are losing serious money.

Novacyt does not have infrastructure to sell worldwide. India and Brazil are going for cheaper options. Stop dreaming of worldwide sales.